Clinical trial
Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk…
NCT00031655 · Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Other · Completed
Key facts
| NCT number | NCT00031655 |
|---|---|
| Title | Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission |
| Official title | Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation From HLA Matched Unrelated Donors for Treatment of Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission - A Multicenter Trial |
| Lead sponsor | Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adult Acute Lymphoblastic Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia |
| Intervention type | Biological, Drug, Other, Procedure, Radiation |
| Interventions | nonmyeloablative allogeneic hematopoietic stem cell transplantation, donor lymphocytes, cyclosporine, total-body irradiation, fludarabine phosphate, mycophenolate mofetil, laboratory biomarker analysis, peripheral blood stem cell transplantation |
| Enrollment | 30 |
| Start date | Sep 1, 2001 |
| Primary completion | Aug 1, 2006 |
| Completion | Nov 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 7, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: